Transient elastography and controlled attenuation parameter to evaluate hepatic steatosis and liver stiffness in postpartum patients

References

• Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124–131.
   PubMed Web of Science ®Google Scholar
• Loomba R, Adams LA. The 20% rule of NASH progression: the natural history of advanced fibrosis and cirrhosis caused by NASH. Hepatology. 2019;70(6):1885–1888.
   PubMed Web of Science ®Google Scholar
• Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141(4):1249–1253.
   PubMed Web of Science ®Google Scholar
• Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212–2224.
   PubMed Web of Science ®Google Scholar
• Hershman M, Mei R, Kushner T. Implications of nonalcoholic fatty liver disease on pregnancy and maternal and child outcomes. Gastroenterol Hepatol. 2019;15(4):221–228.
   Google Scholar
• Ajmera VH, Gunderson EP, VanWagner LB, et al. Gestational diabetes mellitus is strongly associated with non-alcoholic fatty liver disease. Am J Gastroenterol. 2016;111(5):658–664.
   PubMed Web of Science ®Google Scholar
• Foghsgaard S, Andreasen C, Vedtofte L, et al. Nonalcoholic fatty liver disease is prevalent in women with prior gestational diabetes mellitus and independently associated with insulin resistance and waist circumference. Diabetes Care. 2017;40(1):109–116.
   PubMed Web of Science ®Google Scholar
• Eddowes PJ, Sasso M, Allison M, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717–1730.
   PubMed Web of Science ®Google Scholar
• de Ledinghen V, Vergniol J, Capdepont M, et al. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. J Hepatol. 2014;60(5):1026–1031.
   PubMed Web of Science ®Google Scholar
• Frank Wolf M, Peleg D, Kariv Silberstein N, et al. Correlation between changes in liver stiffness and preeclampsia as shown by transient elastography. Hypertens Pregnancy. 2016;35(4):536–541.
   PubMed Web of Science ®Google Scholar
• Ammon FJ, Kohlhaas A, Elshaarawy O, et al. Liver stiffness reversibly increases during pregnancy and independently predicts preeclampsia. World J Gastroenterol. 2018;24(38):4393–4402.
   PubMed Web of Science ®Google Scholar
• Deng D, George J, Pasupathy D, et al. Antenatal FibroScan(R) assessment for metabolic associated fatty liver in pregnant women at risk of gestational diabetes from a multiethnic population – a pilot study. Intern Med J. 2021.
   Google Scholar
• Fibroscan procedure for users; 2023. Echosens. Available from: https://www.echosens.com/en-us/fibroscanprocedure/
   Google Scholar
• Mueller S, Seitz HK, Rausch V. Non-invasive diagnosis of alcoholic liver disease. World J Gastroenterol. 2014;20(40):14626–14641.
   PubMed Web of Science ®Google Scholar
• Boursier J, Zarski JP, de Ledinghen V, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013;57(3):1182–1191.
   PubMed Web of Science ®Google Scholar
• Mikolasevic I, Orlic L, Franjic N, et al. Transient elastography (FibroScan((R))) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease – where do we stand? World J Gastroenterol. 2016;22(32):7236–7251.
   PubMed Web of Science ®Google Scholar
• Stenberg Ribeiro M, Hagstrom H, Stal P, et al. Transient liver elastography in normal pregnancy – a longitudinal cohort study. Scand J Gastroenterol. 2019;54(6):761–765.
   PubMed Web of Science ®Google Scholar
• Alese MO, Moodley J, Naicker T. Preeclampsia and HELLP syndrome, the role of the liver. J Matern Fetal Neonatal Med. 2021;34(1):117–123.
   PubMed Web of Science ®Google Scholar
• Duvekot JV, Neven L, De Man R, et al. Transient elastography of the liver forms a new and discriminating measure to rule out AFLP in hypertensive patients. Pregnancy Hypertens. 2015;5(1):2–3.
   Google Scholar
• Vidaeff AC, Saade GR, Sibai BM. Preeclampsia: the need for a biological definition and diagnosis. Am J Perinatol. 2021;38(9):976–982.
   PubMedGoogle Scholar
• Sarkar M, Grab J, Dodge JL, et al. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. J Hepatol. 2020;73(3):516–522.
   PubMed Web of Science ®Google Scholar
• Ciardullo S, Grassi G, Mancia G, et al. Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2022;34(4):365–371.
   PubMed Web of Science ®Google Scholar
• Ampuero J, Aller R, Gallego-Duran R, et al. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH. J Hepatol. 2020;73(1):17–25.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Petracca G, Beatrice G, et al. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut. 2022;71(1):156–162.
   PubMed Web of Science ®Google Scholar
• ACOG practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49–e64.
   PubMed Web of Science ®Google Scholar
• Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105–1116.
   PubMed Web of Science ®Google Scholar
• Ciardullo S, Bianconi E, Zerbini F, et al. Current type 2 diabetes, rather than previous gestational diabetes, is associated with liver disease in U.S. women. Diabetes Res Clin Pract. 2021;177:108879.
   PubMed Web of Science ®Google Scholar